Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $9.81
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops therapies to inhibit frontier targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
See the full interactive analysis & chart →Informational only — not investment advice.